AI-generated summary
The authors studied whether a single intraoperative dose of low-level laser therapy affected kidney scarring in rats with a surgically blocked ureter, a model of chronic kidney disease. They report that treated kidneys showed less fibrosis at 14 days and lower expression of inflammatory and pro-fibrotic markers than untreated obstructed kidneys. The study used an animal model, so the findings may not apply directly to humans.
- Participants
- 32
- Who or what was studied
- 32 Wistar rats that underwent unilateral ureteral obstruction (half received laser therapy to the occluded kidney)
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The study was conducted in rats using an experimental model of unilateral ureteral obstruction, so the results may not translate to human chronic kidney disease.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Power
- 30 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.